Gene · 1406
Papers1,885
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,885
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of The Retinal Progenitor Cells Generated Using Co-Culture Systems. | Cell J | 2022 | 35451582 | PubTator, text mining | PubMed |
| Genetic Testing of Inherited Retinal Disease in Australian Private Tertiary Ophthalmology Practice. | Clin Ophthalmol | 2022 | 35444405 | PubTator, text mining | PubMed |
| Machine Learning Prediction of Non-Coding Variant Impact in Human Retinal cis-Regulatory Elements. | Transl Vis Sci Technol | 2022 | 35435921 | PubTator, text mining | PubMed |
| BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective. | Front Oncol | 2022 | 35433454 | PubTator, text mining | PubMed |
| Functional characterization of variants of unknown significance in a spinocerebellar ataxia patient using an unsupervised machine learning pipeline. | Hum Genome Var | 2022 | 35422034 | PubTator, text mining | PubMed |
| Evaluation of photoreceptor-directed fibroblasts derived from retinitis pigmentosa patients with defects in the EYS gene: a possible cost-effective cellular model for mechanism-oriented drug. | Stem Cell Res Ther | 2022 | 35410372 | PubTator, text mining | PubMed |
| Applying Protein-Protein Interactions and Complex Networks to Identify Novel Genes in Retinitis Pigmentosa Pathogenesis. | Int J Mol Sci | 2022 | 35409321 | PubTator, text mining | PubMed |
| RPE65 c.393T>A, p.(Asn131Lys): Novel Sequence Variant Detected. | Case Rep Ophthalmol Med | 2022 | 35402056 | PubTator, text mining | PubMed |
| Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa. | Stem Cell Res Ther | 2022 | 35395806 | PubTator, text mining | PubMed |
| FZD4 in a Large Chinese Population With Familial Exudative Vitreoretinopathy: Molecular Characteristics and Clinical Manifestations. | Invest Ophthalmol Vis Sci | 2022 | 35394490 | PubTator, text mining | PubMed |
| Diagnostic value of chest radiography in the early management of severely injured patients with mediastinal vascular injury. | Eur J Trauma Emerg Surg | 2022 | 35389063 | PubTator, text mining | PubMed |
| Identification of a novel compound heterozygous CYP4V2 variant in a patient with autosomal recessive retinitis pigmentosa. | Biomed Rep | 2022 | 35386112 | PubTator, text mining | PubMed |
| The Potential Role of Epigenetic Mechanisms in the Development of Retinitis Pigmentosa and Related Photoreceptor Dystrophies. | Front Genet | 2022 | 35360866 | PubTator, text mining | PubMed |
| MLL5 is involved in retinal photoreceptor maturation through facilitating CRX-mediated photoreceptor gene transactivation. | iScience | 2022 | 35359806 | PubTator, text mining | PubMed |
| Rare and common variants in ROM1 and PRPH2 genes trans-modify Stargardt/ABCA4 disease. | PLoS Genet | 2022 | 35353811 | PubTator, text mining | PubMed |
| Antioxidant and lipid supplementation improve the development of photoreceptor outer segments in pluripotent stem cell-derived retinal organoids. | Stem Cell Reports | 2022 | 35334217 | PubTator, text mining | PubMed |
| One-step induction of photoreceptor-like cells from human iPSCs by delivering transcription factors. | iScience | 2022 | 35330684 | PubTator, text mining | PubMed |
| Human iPSC-Derived Retinal Organoids and Retinal Pigment Epithelium for Novel Intronic RPGR Variant Assessment for Therapy Suitability. | J Pers Med | 2022 | 35330501 | PubTator, text mining | PubMed |
| Pigment Epithelia of the Eye: Cell-Type Conversion in Regeneration and Disease. | Life (Basel) | 2022 | 35330132 | PubTator, text mining | PubMed |
| Retinal Organoids and Retinal Prostheses: An Overview. | Int J Mol Sci | 2022 | 35328339 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1406/papers?page=20